BNET Industries
Hospira Inc. (HSP) is in the Pharma Industry
- Revenue
- Dec 31 2007
- $3.4B
- Profit
- Dec 31 2007
- $136.7M
- Market Cap
- Nov 28 2008
- $4.7B
Latest News and Analysis
Hospira Inc. Q3 2008 Earnings Call Transcript
Question-and-Answer Session[Operators Instructions]. Our first question comes from the line of Gregg Gilbert with Merrill Lynch. Gregg Gilbert - Merrill Lynch Thanks good morning. First one's for Tom, on currency perhaps you could help us based on current rates what would you expect the impact on '09 in revenues...
Market briefs.(Business)
Hospira posts first-quarter loss Hospira Inc., a Lake Forest maker of drugs and devices used by hospitals, reported a first-quarter loss because of costs tied to its purchase of an Australian company. The loss of $29.4 million, or 19 cents a share, during the...
Stock Alert for LLSR! January 23, 2007.
M2 PRESSWIRE-23 January 2007-Stock Market Alerts LLC: Stock Alert for LLSR! January 23, 2007C1994-2007 M2 COMMUNICATIONS LTD RDATE:23012007 Miami, FLA. - Stock Market Alert's performance stock list includes: Lantis Laser Inc. (OTC: LLSR), American Dental Partners, Inc., (NASDAQ: ADPI), Patterson Companies,...
Stock Movers of Note 06/01.
M2 PRESSWIRE-1 June 2005-StreetInsider.com: Stock Movers of Note 06/01C1994-2005 M2 COMMUNICATIONS LTD RDATE:01062005 Streetinsider.com's Stock Movers of Note: Physiometrix, Inc. (Nasdaq: PHYX), Hospira, Inc. (NYSE: HSP), School Specialty, Inc. (Nasdaq: SCHS), United Online Inc (Nasdaq: UNTD), SBC (NYSE: SBC), Engineered...
To cherish
Tiffany Danielle Hampton and James Wells Beckom Jr. married at the Sandals Negril Beach Resort and Spa in Negril, Jamaica The bride, a grad of Southern Illinois University at Carbondale, is a systems analyst for Abbott Laboratories The groom, a grad of the Univ. of Illinois at Urbana-Champaign and Loyola...
For The Record.(Briefs)(Brief Article)
Spiegel is telling potential buyers not to bother with offers for its Eddie Bauer chain unless they are substantially more than what the Downers Grove cataloger has seen so far. Prime Group Realty Trust said a joint venture formed by investor E. Barry Mansur...
Medical Stocks In Motion: Stocks To Keep An Eye On: PLYCF, ACL, HSP, ABT, ESRX.
M2 PRESSWIRE-11 August 2004-InvestSource Inc.: Medical Stocks In Motion: Stocks To Keep An Eye On: PLYCF, ACL, HSP, ABT, ESRXC1994-2004 M2 COMMUNICATIONS LTD RDATE:08112004 Stocks in the news: PlayStar Corporation (OTC: PLYCF), Alcon Incorporated (NYSE: ACL), Lasik America Incorporated, Hospira Inc....
Additional Resources
Yankee Equity Solution Launches $50 Million Fund for Mass.-Based Medtech Companies
BOSTON -- Yankee Equity Solution YES has launched the $50 million "YES Medical Technology Fund", a private equity vehicle to help Mass.-based medical technology companies with revenues and profits to expand their commercialization efforts. Specifically, the YES Medical Technology Fund will provide growth capital to medtech companies that have revenues...
Hospira Names Ken Meyers to Lead Human Resources
LAKE FOREST, Ill., Nov. 10 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, announced today that Ken Meyers has been named senior vice president, Organizational Transformation and People Development. In this capacity, he will lead the global human resources function with a focus on...
Supplier Added to Premier Healthcare Alliance's New Comprehensive IV Therapy Products Portfolio
CHARLOTTE, N.C. -- Premier Purchasing Partners, LP, today announced that Smiths Medical MD Inc. of St. Paul, Minn., has been added to its new portfolio for IV Therapy Products, becoming the ninth company awarded a contract. Eight companies were announced in August. The portfolio is divided in four...
Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
- Treatment completed in AlbuferonR Phase 3 trials; first Phase 3 data in December 2008 - - Enrollment completed in LymphoStat-BR Phase 3 trials; first Phase 3 data in mid-2009 - - HGS updates financial guidance - ROCKVILLE, Md., Nov. 6 /PRNewswire-FirstCall/ --...
Hospira Reports Third-Quarter 2008 Results
-- Reaffirms 2008 adjusted* earnings projection -- LAKE FOREST, Ill., Nov. 5 /PRNewswire-FirstCall/ -- Hospira, Inc. , a leading global specialty pharmaceutical and medication delivery company, today reported results for the third quarter of 2008. -- Net sales increased 10.4 percent to $925.5 million during...
Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
LAKE FOREST, Ill., Nov. 4 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, today announced that Christopher B. Begley, chairman and chief executive officer, and Thomas E. Werner, senior vice president, Finance, and chief financial officer, will make a formal presentation at the 2008...
Applied NeuroSolutions Announces Addition of Diagnostic Healthcare Executive Edward Ogunro, Ph.D., to Board of Directors
VERNON HILLS, Ill. -- Applied NeuroSolutions, Inc. (OTC BB:APNS)(www.appliedneurosolutions.com), a Company focused on the development of an integrated product portfolio for the treatment and diagnosis of Alzheimer's disease AD, today announced the appointment of Edward A. Ogunro, Ph.D., a diagnostic and pharmaceutical industry veteran, to its Board of Directors. ...
FDA Approves New Indication for Hospira's Precedex Injection
- Expands Therapy to Broader Patient Population - LAKE FOREST, Ill., Oct. 30 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, announced today that the U.S. Food and Drug Administration FDA approved a new indication for PrecedexR, the company's innovative drug for...
StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists
MENLO PARK, Calif., Oct. 22 /PRNewswire/ -- StemCor Systems, Inc., a medical device company developing systems for Enabling Regenerative MedicineTM, announced today that it has signed an agreement with Hospira, Inc. to develop and commercialize StemCor's proprietary System for the harvest of bone marrow. (Logo: ...
Awards for Supply Management Excellence to Be Presented at Aberdeen Group's Chief Procurement Officer's Summit
Aberdeen Group, a Harte-Hanks Company (NYSE: HHS), will reveal the winners of its industry achievement awards in globalsupply management at its 4th annual Chief Procurement Officer's CPOSummit on November 13-14, 2008 in San Francisco, CA. Aberdeen will presentfive companies with Global Supply Management Achievement Awards forexcellence demonstrated in 5 specific...
Hospira Acquires EndoTool From MD Scientific
- Innovative glucose control management system helps enhance quality of care and patient safety - LAKE FOREST, Ill., Oct. 13 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, announced today that it has acquired the EndoToolR business from MD Scientific, LLC. The...
Circassia Acquires North American and Japanese Rights to Dopexamine
Circassia Establishes Commercial-Scale Supply Chain Circassia to Develop Dopexamine as Part of Proprietary Post-Surgery Recovery Protocols OXFORD, England, October 8 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on the fields of allergy and critical care, announced today that it has acquired the US,...
Hospira Hosts Conference Call for Third-Quarter 2008 Earnings
LAKE FOREST, Ill., Oct. 7 /PRNewswire-FirstCall/ -- Hospira, Inc. , a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its third-quarter 2008 results on Wednesday, Nov. 5, 2008, at 8 a.m. Central time. The company will...
- Next »
- page 1 of 1
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- Incorporated: 2003
- CEO: Mr. Christopher B. Begley
Hospira is a global specialty pharmaceutical and medication delivery company focusing on products that improve the productivity, safety and efficacy of patient care in the acute care setting. Co. is engaged in the development, manufacture and marketing of specialty injectable pharmaceuticals and medication delivery systems that deliver drugs and intravenous fluids. Co. provides contract manufacturing services to pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals. Co.'s products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.
Key Competitors
Industry Transcripts by Seeking Alpha
-
Indevus Pharmaceuticals, Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 25, 2008about IDEV
-
Noven Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about NOVN
-
XenoPort, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about XNPT
-
Repligen Corporation F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 24, 2008about RGEN
-
Omrix Biopharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about OMRI
Hospira Inc. Company Info
Board of Directors
Mr. Christopher B. Begley
Chairman
Miss Barbara L. Bowles
Mr. Irving W. Bailey II
Lead Director
Mr. Ronald A. Matricaria
Dr. Jacque J. Sokolov M.D.
Mr. Roger W. Hale
Mr. John C. Staley
Dr. Connie R. Curran Ed.D.
Dr. Mark F. Wheeler M.D.
Contact Information
275 North Field Drive
Lake Forest, IL
224 212-2000